Viewing Study NCT00287495

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2025-12-25 @ 4:36 PM
Study NCT ID: NCT00287495
Status: TERMINATED
Last Update Posted: 2019-12-12
First Post: 2006-02-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kaposi's Sarcoma View
None HHV-8 View
None KSHV View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AIDS View
None HIV View
None Antiangiogenesis View
None VEGF View
None AIDS Malignancy View
None Kaposi Sarcoma View
None KS View